Publication | Closed Access

Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival

Extracellular Superoxide DismutaseTranslational MedicineHeart FailureMedicineIschemic Reperfusion InjuryImmunologyGene DeliveryGene VectorPre-emptive Gene TherapyCell EngineeringCell TransplantationCardiologyNovel Therapy